Cytomegalovirus (CMV) genotype in allogeneic hematopoietic stem cell transplantation
Open Access
- 10 July 2013
- journal article
- research article
- Published by Springer Science and Business Media LLC in BMC Infectious Diseases
- Vol. 13 (1), 310-8
- https://doi.org/10.1186/1471-2334-13-310
Abstract
Based on sequence variation in the UL55 gene that encodes glycoprotein B (gB), human cytomegalovirus (CMV) can be classified into four gB genotypes. Previous studies have suggested an association between CMV gB genotype and clinical outcome in patients who underwent an allogeneic hematopoietic stem cell transplant (HSCT). The goals of this study were identify patients with active infection caused by CMV in recipients of HSCT; determine the prevalence of CMV genotypes in the study group; correlate genotype with CMV disease, acute GVHD and overall survival. The diagnosis of active CMV infection after allogeneic HSCT was detected by antigenemia (AGM) and/or nested-PCR (N-PCR). Positive samples from patients with active CMV infection were submitted to genotyping using N-PCR to amplify a region of UL55, followed by restriction analysis based on HinfI and RsaI digestion. Real-time PCR (qPCR) was used to determine the viral load during active CMV infection and antiviral treatment. Sixty-three allogeneic HSCT recipients were prospectively evaluated; 49/63 (78%) patients were infected with CMV genotypes – gB1 19/49 (39%), gB2 17/49 (35%), gB3 3/49 (6%), gB4 7/49 (14%) – and 3 (6%) had mixed CMV genotypes (gB1 + gB3, gB1 + gB4 and gB2 + gB4). Characterized by gastrointestinal disease, CMV disease occurred in 3/49 (6.1%) patients, who had CMV gB3 genotype. These gB3 genotype patients presented an increasing AGM number, mean 125 (± 250) (P = 0.70), and qPCR copies/ml, mean 37938 (SD ± 50542) (P = 0.03), during antiviral treatment, when compared with other CMV genotypes. According to CMV genotypes, stratified overall survival was 55% for gB1, 43% for gB2; 0% for gB3 and 57% for gB4 (P = 0.03). One of the restrictions of the presented study was the low number of CMV gB sub-cohorts). However, we demonstrated that the frequency of active CMV infection in this HSCT population was high, and the most prevalent genotype in these patients with active CMV infection was gB1 and gB2 genotype (74%). In Brazil, HSCT recipients seem to carry mainly gB1 and gB2 CMV genotype.Keywords
This publication has 64 references indexed in Scilit:
- Occurrence of Human Cytomegalovirus Glycoprotein B Genotypes in Immunocompetent and Immunosuppressed Taiwanese PatientsIntervirology, 2011
- Surveillance of active human cytomegalovirus infection in hematopoietic stem cell transplantation (HLA sibling identical donor): search for optimal cutoff value by real-time PCRBMC Infectious Diseases, 2010
- Cytomegalovirus Glycoprotein B Genotype in Hematopoietic Stem Cell Transplant Patients from ChinaTransplantation and Cellular Therapy, 2010
- Active human Cytomegalovirus infection and Glycoprotein B genotypes in Brazilian pediatric renal or hematopoietic stem cell transplantation patientsBrazilian Journal of Microbiology, 2010
- Impact of Genetic Polymorphisms in Cytomegalovirus Glycoprotein B on Outcomes in Solid‐Organ Transplant Recipients with Cytomegalovirus DiseaseClinical Infectious Diseases, 2009
- Obturator hernia: a diagnostic challengeHernia, 2008
- Cytomegalovirus gB Genotype and Clinical Features in Chinese Infants with Congenital InfectionsIntervirology, 2006
- Totally extraperitoneal repair of obturator herniaSurgical Endoscopy, 2004
- The amino terminus of human cytomegalovirus glycoprotein B contains epitopes that vary among strainsJournal of General Virology, 1992
- A Major Neutralizing Domain Maps within the Carboxyl-terminal Half of the Cleaved Cytomegalovirus B GlycoproteinJournal of General Virology, 1989